| A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT02966756) | AbbVie | 2017-10-12 |
| Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma (NCT03376737) | Henan Cancer Hospital | 2017-10-12 |
| Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03194373) | University of Michigan Rogel Cancer Center | 2017-10-12 |
| Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance (NCT03267654) | Qilu Pharmaceutical Co., Ltd. | 2017-10-12 |
| A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI (NCT03236311) | Sanofi | 2017-10-12 |
| A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa (NCT03019406) | Genzyme, a Sanofi Company | 2017-10-12 |
| ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) (NCT03362190) | Ophthotech Corporation | 2017-10-11 |
| Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels (NCT02867020) | Latin American Cooperative Oncology Group | 2017-10-11 |
| Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation (NCT03318939) | Spectrum Pharmaceuticals, Inc | 2017-10-11 |
| Hepatitis B Vaccine for Non-responders (NCT03415672) | Maastricht University Medical Center | 2017-10-11 |
| Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a (NCT03320265) | Athera Biotechnologies AB | 2017-10-11 |
| Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis (NCT03315130) | Ra Pharmaceuticals | 2017-10-11 |
| Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance (NCT03227926) | Fondazione del Piemonte per l'Oncologia | 2017-10-11 |
| Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy (NCT03148327) | Jonsson Comprehensive Cancer Center | 2017-10-11 |
| The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia (NCT03304288) | Peking University People's Hospital | 2017-10-11 |
| A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer (NCT03288545) | Astellas Pharma Global Development, Inc. | 2017-10-11 |
| Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age (NCT03313037) | Pfizer | 2017-10-10 |
| Evaluating the Role of Neuroinflammation in Low Back Pain (NCT03106740) | Marco Loggia | 2017-10-10 |
| CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM) (NCT03317028) | Center Laboratories, Inc. | 2017-10-10 |
| Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion (NCT03101371) | University of Colorado, Denver | 2017-10-10 |
| TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT03123393) | Calithera Biosciences, Inc | 2017-10-10 |
| A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment (NCT04109183) | Henan Genuine Biotech Co., Ltd. | 2017-10-10 |
| Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole (NCT03250117) | Titan Pharmaceuticals | 2017-10-10 |
| Molecular Imaging of NET Using [C-11]MRB-PET in MS (NCT03207464) | Brigham and Women's Hospital | 2017-10-10 |
| Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS) (NCT03268603) | Mayo Clinic | 2017-10-10 |
| Clinical Outcomes With Electroconvulsive Therapy: Insights From Computational Modelling (NCT03297411) | The University of New South Wales | 2017-10-10 |
| Treatment With Tamoxifen in Cryptococcal Meningitis (NCT03112031) | Oxford University Clinical Research Unit, Vietnam | 2017-10-10 |
| SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx (NCT03220854) | Virginia Commonwealth University | 2017-10-10 |
| Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD) (NCT02715505) | Novartis Pharmaceuticals | 2017-10-10 |
| Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris (NCT03322137) | Sienna Biopharmaceuticals | 2017-10-10 |
| Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD (NCT03306888) | Teachers College, Columbia University | 2017-10-10 |
| Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma (NCT03206060) | National Cancer Institute (NCI) | 2017-10-10 |
| Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma (NCT03019640) | M.D. Anderson Cancer Center | 2017-10-10 |
| TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer (NCT03093350) | Baylor College of Medicine | 2017-10-10 |
| Osimertinib Treatment on EGFR T790M Plasma Positive NSCLC Patients (APPLE) (NCT02856893) | European Organisation for Research and Treatment of Cancer - EORTC | 2017-10-10 |
| MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women (NCT03291067) | Tanabe Pharma America, Inc. | 2017-10-09 |
| TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer (NCT03287674) | Inge Marie Svane | 2017-10-09 |
| A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies (NCT03241173) | Incyte Biosciences International Sàrl | 2017-10-09 |
| High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients (NCT03179761) | Vanderbilt-Ingram Cancer Center | 2017-10-09 |
| Ga-68-PSMA-11 in High-risk Prostate Cancer (NCT03362359) | German Cancer Research Center | 2017-10-09 |
| Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide (NCT02991456) | Duke University | 2017-10-09 |
| A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas (NCT03405454) | National University Hospital, Singapore | 2017-10-09 |
| FMT in Pediatric Crohn's Disease (NCT03194529) | Children's Hospital Los Angeles | 2017-10-09 |
| Effect of Methylphenidate on Cancer-related Cognitive Impairment (NCT02970500) | CHU de Quebec-Universite Laval | 2017-10-09 |
| Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome (NCT03184584) | Liminal BioSciences Ltd. | 2017-10-09 |
| Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) (NCT03168464) | Weill Medical College of Cornell University | 2017-10-09 |
| Does DHEA IVF Outcomes in Poor Responders? (NCT04066478) | Homerton University Hospital NHS Foundation Trust | 2017-10-08 |
| A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (NCT03219333) | Astellas Pharma Inc | 2017-10-08 |
| Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples (NCT05138978) | Colgate Palmolive | 2017-10-06 |
| Safety and Tolerability of Sodium Thiosulfate in Patients With an ACS Undergoing CAG Via Trans-radial Approach. (NCT03017963) | University Medical Center Groningen | 2017-10-06 |
| A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients (NCT03239691) | Idorsia Pharmaceuticals Ltd. | 2017-10-06 |
| The Effect of Cannabis in Pancreatic Cancer (NCT03245658) | Jens Rikardt Andersen | 2017-10-06 |
| Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System (NCT03270059) | OHSU Knight Cancer Institute | 2017-10-06 |
| A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers (NCT03303911) | Achieve Life Sciences | 2017-10-06 |
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery (NCT03314025) | CHU de Quebec-Universite Laval | 2017-10-06 |
| Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN) (NCT03285711) | Gilead Sciences | 2017-10-06 |
| Autologous Conditioned Serum: Functional and Clinical Results (NCT03850080) | Ospedale San Raffaele | 2017-10-06 |
| Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC (NCT03099486) | Fox Chase Cancer Center | 2017-10-06 |
| Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers (NCT03423771) | Nihon Pharmaceutical Co., Ltd | 2017-10-06 |
| APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers (NCT03165994) | Apexigen America, Inc. | 2017-10-06 |
| ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients (NCT03334240) | Maruho Co., Ltd. | 2017-10-05 |
| Long-Term Safety Study of Tafenoquine (NCT03320174) | 60 Degrees Pharmaceuticals LLC | 2017-10-05 |
| Effect of Inhaled Albuterol in Pulmonary Hypertension (NCT03270332) | University of Miami | 2017-10-05 |
| Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients (NCT04659551) | Istituto Oncologico Veneto IRCCS | 2017-10-05 |
| A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris (NCT03307577) | Therapeutics, Inc. | 2017-10-05 |
| Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome (NCT03325010) | Neurocrine Biosciences | 2017-10-05 |
| Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis (NCT03267277) | National Institute of Environmental Health Sciences (NIEHS) | 2017-10-05 |
| A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris (NCT03170388) | Bausch Health Americas, Inc. | 2017-10-05 |
| Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide (NCT03185819) | Janssen Research & Development, LLC | 2017-10-05 |
| VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer (NCT03268057) | Vaccinex Inc. | 2017-10-05 |
| Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients (NCT03272477) | Palleos Healthcare GmbH | 2017-10-05 |
| A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis (NCT03163966) | Rottapharm Biotech | 2017-10-05 |
| Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma (NCT03319537) | Memorial Sloan Kettering Cancer Center | 2017-10-05 |
| Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients (NCT03205150) | Novartis Pharmaceuticals | 2017-10-04 |
| BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence (NCT03320850) | Allergan | 2017-10-04 |
| Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer (NCT03217071) | Sue Yom | 2017-10-04 |
| Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery (NCT03307616) | M.D. Anderson Cancer Center | 2017-10-04 |
| Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder (NCT03209102) | Institut National de la Santé Et de la Recherche Médicale, France | 2017-10-04 |
| Study of AGEN1884 With Pembrolizumab in 1L NSCLC (NCT03411473) | Agenus Inc. | 2017-10-04 |
| Age of Blood in Sickle Cell Transfusion (NCT03704922) | University of North Carolina, Chapel Hill | 2017-10-04 |
| Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01) (NCT03230175) | BioTissue Holdings, Inc | 2017-10-04 |
| A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma (NCT03215030) | Teva Branded Pharmaceutical Products R&D LLC | 2017-10-04 |
| A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris (NCT03599193) | Dr. Reddy's Laboratories Limited | 2017-10-04 |
| A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis (NCT03215277) | UCB Biopharma SRL | 2017-10-04 |
| A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease (NCT03289143) | Genentech, Inc. | 2017-10-04 |
| Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC (NCT03263650) | M.D. Anderson Cancer Center | 2017-10-03 |
| Sirolimus and Familial Adenomatous Polyposis (FAP) (NCT03095703) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2017-10-03 |
| Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT (NCT03283566) | The Cleveland Clinic | 2017-10-03 |
| Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells (NCT03242603) | National University Hospital, Singapore | 2017-10-03 |
| Nivolumab Plus Ipilimumab in Thyroid Cancer (NCT03246958) | Dana-Farber Cancer Institute | 2017-10-03 |
| Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough (NCT03282591) | Vyne Therapeutics Inc. | 2017-10-03 |
| Nabilone for Non-motor Symptoms in Parkinson's Disease (NCT03769896) | Medical University Innsbruck | 2017-10-03 |
| Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents (NCT03242915) | University of Michigan Rogel Cancer Center | 2017-10-03 |
| Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine (NCT03885154) | Kimberly S Jones | 2017-10-03 |
| Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (NCT03132675) | OncoSec Medical Incorporated | 2017-10-03 |
| Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) (NCT03263559) | Medical College of Wisconsin | 2017-10-03 |
| Autologous Dendritic Cell Vaccination in Mesothelioma (NCT02649829) | University Hospital, Antwerp | 2017-10-03 |
| RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer (NCT03189914) | Processa Pharmaceuticals | 2017-10-02 |
| Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer. (NCT03315754) | Steba Biotech S.A. | 2017-10-02 |
| Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer (NCT03189446) | University of Oklahoma | 2017-10-02 |